Researcher
Jurgen Joossens
- Keywords:Pharmacy and pharmacology
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal chemistry, Medicinal products, Pharmaceutical analysis and quality assurance, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Other medical and health sciences
Affiliations
- Tech Transfer Office (TTO) (Research group)
Responsible
From1 Nov 2016 → Today - Medicinal Chemistry (UAMC) (Research group)
Member
From1 Oct 2005 → 31 Oct 2016
Projects
1 - 10 of 22
- SkillsApp, market exploration and validation of innovative web application to objectify skills evaluation.From1 May 2024 → TodayFunding: IOF - technology validation in lab
- AI-driven optimalisation of the user experience (UX) of digital tools.From1 Sep 2023 → TodayFunding: IOF - technology concept exploration
- CremAN: Simulating Input/Output and CAN communication for testing remanufactured automotive parts.From1 May 2023 → TodayFunding: IOF - technology concept exploration
- Optimization of the cryopreservation procedure of cells for therapeutic and research applications using Design of Experiments.From1 Jan 2023 → 31 Dec 2023Funding: IOF - technology concept exploration
- IOF Alliance Valorisation Manager UAntwerpen - UZAFrom7 Nov 2022 → TodayFunding: IOF - mandates
- IOF Valorisation Life SciencesFrom7 Mar 2022 → TodayFunding: IOF - mandates
- Development of a cascading approach for zero-waste valorization of agricultural and food residues.From1 Dec 2021 → 30 Nov 2023Funding: IOF - technology concept exploration
- IOF Valorisation - Project DevelopmentFrom1 Jul 2021 → TodayFunding: IOF - mandates
- Towards integrated Practices of Schools, Reception Centres and Leisure Time Facilities for Refugee Children: an Action Research.From1 May 2021 → 30 Apr 2023Funding: IOF - technology concept exploration
- IOF Valorisation of social and human sciences.From1 Mar 2021 → TodayFunding: IOF - mandates
Publications
11 - 20 of 50
- Carboxylate isosteres for caspase inhibitors(2017)
Authors: Yves Adriaenssens, D. Jiménez Fernández, L. Vande Walle, Filipe Elvas, Jurgen Joossens, Anne-Marie Lambeir, Koen Augustyns, M. Lamkanfi, Pieter Van Der Veken
Pages: 7456 - 7473 - Selective glucocorticoid receptor properties of GSK866 analogs with cysteine reactive warheads(2017)
Authors: Chandra Sekhar Chirumamilla, Ajay Palagani, Balu Kamaraj, Ken Declerck, Marinus W.C. Verbeek, Oksana Ryabtsova, Karolien De Bosscher, Nadia Bougarne, Bart Ruttens, Kris Gevaert, et al.
Pages: 1 - 17 - Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity(2017)
Authors: Eleni Pitta, Olga Balabon, Maciej Rogacki, Jesús Gómez, Fraser Cunningham, Jurgen Joossens, Koen Augustyns, Pieter Van Der Veken, Robert Bates
Pages: 890 - 901 - Regulation of intestinal permeability(2017)
Authors: Hanne Van Spaendonk, Hannah Ceuleers, Leonie Witters, Eveline Patteet, Jurgen Joossens, Koen Augustyns, Anne-Marie Lambeir, Ingrid De Meester, Joris De Man, Benedicte De Winter
Pages: 2106 - 2123 - Preclinical evaluation of [$^{111}In$]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity(2016)
Authors: Christel Vangestel, David Thomae, Jeroen Van Soom, Johan Ides, Leonie Wyffels, Patrick Pauwels, Sigrid Stroobants, Pieter Van Der Veken, Viktor Magdolen, Jurgen Joossens, et al.
Pages: 448 - 458 - Searching for new leads for tuberculosis(2016)
Authors: Eleni Pitta, Maciej K. Rogacki, Olga Balabon, Sophie Huss, Fraser Cunningham, Eva Maria Lopez-Roman, Jurgen Joossens, Koen Augustyns, Lluis Ballell, Robert H. Bates, et al.
Pages: 6709 - 6728 - Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398(2016)
Authors: Kevin Ariën, Muthusamy Venkatraj, Johan Michiels, Jurgen Joossens, Katleen Vereecken, Pieter Van Der Veken, Jan Heeres, Hans De Winter, Leo Heyndrickx, Koen Augustyns, et al.
Pages: 1159 - 1168 - Intellectual property management in academic drug discovery(2016)
Authors: Pieter-Jan Guns, Jurgen Joossens
Pages: 83 - 85 - Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting(2016)
Authors: Agnese Maggi, Eduardo Ruivo, Jens Fissers, Christel Vangestel, Sneha Chatterjee, Jurgen Joossens, Frank Sobott, Steven Staelens, Sigrid Stroobants, Pieter Van Der Veken, et al.
Pages: 7544 - 7551 - Substrate activity screening (SAS) and related approaches in medicinal chemistry(2016)
Authors: Rafaela Gladysz, Anne-Marie Lambeir, Jurgen Joossens, Koen Augustyns, Pieter Van Der Veken
Pages: 467 - 476
Patents
1 - 10 of 10
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- Halogenated benzotropolones as ATG4B inhibitors (Inventor)
- Halogenated benzotropolones as atg4b inhibitors (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- KLK4 inhibitors (Inventor)
- Halogenated benzotropolones as atg4b inhibitors (Inventor)
- Triazines with suitable spacers for treatment and/or prevention of HIV infections (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)